Bupropion and Weight Control for Smoking Cessation - 1

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco abstinence in women.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Pittsburgh
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Bupropion

Criteria

Inclusion Criteria:

• Smoke at least 10 cigarettes per day

• Report concern about cessation-related weight gain

• Motivated to quit smoking

Exclusion Criteria:

• Currently pregnant, lactating, or no medically approved method of contraception

• Major medical problem

• History of seizure disorder or head injury

• Current or historical psychosis or bipolar disorder

• History of alcohol or substance abuse within previous year

• Current or historical eating disorder

• Use of antidepressant medication, monoamine oxidase inhibitor or lithium with previous month

• Multiple Drug Allergies

• Current major depressive disorder